Docaravimab
Product Specifications
CAS Number
2247196-23-0
Target
Others
Related Pathways
Others
Bioactivity
Docaravimab, an antibody designed to target the G-III epitope within the ectodomain of the Evelyn-Rockitniki-Abelseth (ERA) glycoprotein, is utilized in rabies research [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1055724-01 0.02 mg (E-Coli)
Recombinant Oligotropha carboxidovorans NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details 
MBS1055724-02 0.1 mg (E-Coli)
Recombinant Oligotropha carboxidovorans NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details MBS1055724-03 0.02 mg (Yeast)
Recombinant Oligotropha carboxidovorans NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details MBS1055724-04 0.1 mg (Yeast)
Recombinant Oligotropha carboxidovorans NADH-quinone oxidoreductase subunit B (nuoB)
Ask
View Details